Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What to Watch Monday, May 5: Earnings From Drug Giant Pfizer (video)
The Street
Sunday, May 4, 2014 - 11:50am
tags:
Pfizer, earnings
Big Pharma stands to profit by cleaning out its medicine chests
Yahoo/Reuters
Sunday, May 4, 2014 - 11:47am
tags:
Novartis - Outstanding Strategic Initiatives Rendering The Sluggish Growth Irrelevant
Seeking Alpha
Sunday, May 4, 2014 - 11:45am
tags:
Novartis
China Biotech Week In Review: Pfizer's Attempt To Acquire AstraZeneca Could Run Into Trouble
Seeking Alpha
Sunday, May 4, 2014 - 11:44am
tags:
Pfizer, AstraZeneca, Zhejiang Hisun Pharma, Ambrx, Sinovac Biotech, Hutchison MediPharma, TaiGen Biotechnology, WuXi PharmaTech, Concord Medical Services
1 Pipeline All Investors Need to Know
Motley Fool
Sunday, May 4, 2014 - 11:42am
tags:
Merck, pipelines
Novartis Earnings: What Investors Need to Know
Motley Fool
Sunday, May 4, 2014 - 11:41am
tags:
Novartis, earnings
Novavax's VP of R&D Says Production of MERS Vaccine is Analagous to Situation Described in NEJM Paper on H7n9
Yahoo/Benzinga
Sunday, May 4, 2014 - 11:39am
tags:
Novavax, vaccines, MERS virus
Why the Market Is Wrong About Biogen Idec Inc.
Motley Fool
Sunday, May 4, 2014 - 11:38am
tags:
Biogen Idec
Repligen: A Strong Investment For The Right Kind Of Investor
Seeking Alpha
Sunday, May 4, 2014 - 11:36am
tags:
Repligen
Sun Pharma to close its Detroit facility
DNA India
Saturday, May 3, 2014 - 11:37am
tags:
Shasun Pharma
Eli Lilly Earnings: What Investors Need to Know
Motley Fool
Saturday, May 3, 2014 - 11:35am
tags:
Eli Lilly, earnings
Meet Lung Cancer's New Enemy
Motley Fool
Saturday, May 3, 2014 - 11:31am
tags:
Novartis, lung cancer, Zykadia
Pfizer U.S. research jobs jeopardized by promises to UK for merger
Yahoo/Reuters
Saturday, May 3, 2014 - 11:30am
tags:
Pfizer, AstraZeneca, M&A
We Don't Want Pfizer To Guarantee Jobs And Investment If It Buys AstraZeneca
Forbes
Saturday, May 3, 2014 - 11:20am
tags:
Pfizer, AstraZeneca, M&A
Down 62%: Is Endocyte a Bad News Buy?
Motley Fool
Saturday, May 3, 2014 - 11:18am
tags:
Endocyte
Geron And The Mayo Clinic Working In Parallel To Release Clinical Hold Of Imetelstat
Seeking Alpha
Saturday, May 3, 2014 - 11:15am
tags:
Geron, imetelstat, myelofibrosis
Arena Pharma Denied Request Added Market Exclusivity for Weight-Loss Drug
TheStreet.com
Friday, May 2, 2014 - 11:55am
tags:
Arena Pharmaceuticals, market exclusivity, FDA, Eisai, Belviq
Amid Zohydro controversy, Teva, Purdue and Pfizer race ahead with new pain drugs
Fierce Biotech
Friday, May 2, 2014 - 11:30am
tags:
Purdue Pharma, Pfizer, Teva Pharmaceuticals, Zogenix, Zohydro, painkillers, hydrocodone
Pfizer jumps on the microbiome bandwagon with expansive Second Genome deal
Fierce Biotech
Friday, May 2, 2014 - 11:28am
tags:
Second Genome, Pfizer, obesity, microbiome
Earnings Preview: Pfizer looks for earnings boost from Lyrica others
The Fly on the Wall
Friday, May 2, 2014 - 11:27am
tags:
Pfizer, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.